Thalidomide on the comeback trail

被引：67

作者：

Hales, BF ^{[1
]}

机构：

[1] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada

来源：

NATURE MEDICINE | 1999年 / 5卷 / 05期

关键词：

D O I：

10.1038/8371

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Will new insights into Thalidomide's teratogenic mechanism help make its return a safe one (pages 582–585)?

引用

页码：489 / 490

页数：2

共 12 条

[1]

Arlen RR, 1996, J PHARMACOL EXP THER, V277, P1649

[2]

Castilla EE, 1996, TERATOLOGY, V54, P273, DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO

[3]

2-#

[4]

LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555

[5]

MCBRIDE WG, 1961, LANCET, V2, P1358

[6]

OZOLINS TRS, IN PRESS BIOCH PHARM

[7] Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity [J].

Parman, T ;

Wiley, MJ ;

Wells, PG .

NATURE MEDICINE, 1999, 5 (05) :582-585

[8] Reactive oxygen species participate in the control of mouse embryonic cell death [J].

Salas-Vidal, E ;

Lomeli, H ;

Castro-Obregón, S ;

Cuervo, R ;

Escalante-Alcalde, D ;

Covarrubias, L .

EXPERIMENTAL CELL RESEARCH, 1998, 238 (01) :136-147

[9] THALIDOMIDE SELECTIVELY INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY STIMULATED HUMAN MONOCYTES [J].

SAMPAIO, EP ;

SARNO, EN ;

GALILLY, R ;

COHN, ZA ;

KAPLAN, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :699-703

[10]

SCHARDEIN JL, 1993, CHEM INDUCED BIRTH D, V8, P208

← 1 2 →